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hoA activity is transiently inhibited at the initial
phase of integrin engagement, when Cdc42- and/or
Rac1-mediated membrane spreading and rufﬂing
predominantly occur. Paxillin, an integrin-assembly protein,
has four major tyrosine phosphorylation sites, and the
phosphorylation of Tyr31 and Tyr118 correlates with cell
adhesion and migration. We found that mutation of Tyr31/118
caused enhanced activation of RhoA and premature
formation of stress ﬁbers with substantial loss of efﬁcient
membrane spreading and rufﬂing in adhesion and migration
of NMuMG cells. These phenotypes were similar to those
induced by RhoA(G14V) in parental cells, and could be
abolished by expression of RhoA(T19N), Rac1(G12V), or
p190RhoGAP in the mutant-expressing cells. Phosphorylated
R
 
Tyr31/118 was found to bind to two src homology (SH)2
domains of p120RasGAP, with coprecipitation of endogenous
paxillin with p120RasGAP. p190RhoGAP is known to be a
major intracellular binding partner for the p120RasGAP
SH2 domains. We found that Tyr31/118-phosphorylated
paxillin competes with p190RhoGAP for binding to
p120RasGAP, and provides evidence that p190RhoGAP
freed from p120RasGAP efﬁciently suppresses RhoA activity
during cell adhesion. We conclude that Tyr31/118-phos-
phorylated paxillin serves as a template for the localized
suppression of RhoA activity and is necessary for efﬁcient
membrane spreading and rufﬂing in adhesion and migration
of NMuMG cells.
 
Introduction
 
The Rho-family GTPases, RhoA, Rac1, and Cdc42, play
essential roles in the formation and remodeling of intracellular
actin-based structures (for review see Hall, 1998). These
Rho-family GTPases can be activated by integrin signaling
(Barry et al., 1997; Clark et al., 1998; Price et al., 1998; Ren
and Schwartz, 1998; del Pozo et al., 2000; Cox et al., 2001).
RhoA activity is primarily responsible for the formation of
actin stress fibers (Ridley et al., 1992), which potentially exert
contractile force and are necessary for the maintenance of
sufficient adhesion to substrates. However, RhoA activity is
transiently down-regulated at the initial phase of integrin
activation during cell adhesion to the extracellular matrix
(Ren et al., 1999; Arthur et al., 2000), when Cdc42- and/or
Rac1-mediated active membrane spreading and ruffling
predominantly occur (Price et al., 1998; Arthur and Burridge,
2001; Cox et al., 2001). Thus, the precise regulation of
RhoA activity, both temporally and spatially within a single
cell, probably in concert with activities of other small
GTPases, such as Rac1 and Cdc42, is crucial for efficient cell
adhesion and migration. Although factors regulating RhoA
activity have been well documented, molecular mechanisms
for such localized regulation of RhoA activity still remain
largely unknown.
Paxillin, an integrin assembly adaptor protein (for review
see Turner, 2000), is recruited to the leading cell edges
promptly upon the initiation of migration (Nakamura et
al., 2000; Laukaitis et al., 2001). Paxillin has four major tyro-
sine phosphorylation sites—Tyr31, Tyr40, Tyr118, and
Tyr181—and phosphorylation of Tyr31 and Tyr118 is
highly augmented during cell adhesion and migration, and
present at the leading cell edges of migrating NMuMG normal
epithelial cells (Nakamura et al., 2000). We made two different
paxillin mutants, 2X and 2Y, in which Tyr31/118 and
Tyr40/181 were mutated to phenylalanine, respectively.
Their expression caused altered F-actin organization and loss
of cell polarity, respectively, in motile NMuMG cells, indi-
cating the possible crosstalk between downstream events of
paxillin tyrosine phosphorylation and intracellular regulatory
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mechanism for the activities of Rho-family GTPases (Naka-
mura et al., 2000). Several proteins bearing the src homol-
ogy (SH)*2 domain, including Crk-II and Csk, have been
shown to bind to tyrosine phosphorylated paxillin (for re-
view see Turner, 1998). In Nara Bladder Tumor-II cells,
Crk-II has been shown to function downstream of Tyr31/
118 phosphorylation to promote cell migration (Petit et al.,
2000). On the other hand, Crk-II is unlikely to act as a
downstream factor of paxillin in the case of migration of
NMuMG cells, where Crk-II tightly binds to tyrosine phos-
phorylated p130Cas (Yano et al., 2000). We have also
shown that paxillin and p130Cas, through their tyrosine
phosphorylation, can potentially exert opposing effects on
the haptotactic cell migration and transcellular invasion ac-
tivities of several types of cells, such as NMuMG, COS7,
and MM-1 cells, when these proteins were overexpressed
(Yano et al., 2000). Therefore, the downstream events of ty-
rosine phosphorylation of paxillin may be cell-type specific,
and still remain largely elusive.
Here we report that paxillin phosphorylation at Tyr31/
118 is necessary for efficient membrane spreading and ruf-
fling of NMuMG cells during adhesion and migration, by
suppressing RhoA activity. We found that mutation of
Tyr31/118 of paxillin causes aberrant activation of RhoA
and premature formation of actin stress fibers at the cell pe-
riphery. We show that Tyr31/118-phosphorylated paxillin
binds to the two tandem SH2 domains of p120RasGAP
(Trahey et al., 1988). The p120RasGAP SH2 domains
have been shown to bind to tyrosine phosphorylated
p190RhoGAP, as its major intracellular binding partner
(Moran et al., 1991; Settleman et al., 1992b; Bryant et al.,
1995; Hu and Settleman, 1997). We show that binding
of Tyr31/118-phosphorylated paxillin to p120RasGAP
blocked binding of p190RhoGAP to p120RasGAP in
NMuMG cells, and propose a mechanism by which Tyr31/
118-phosphorylated paxillin serves as a template for the sup-
pression of RhoA activity. We also discuss that both paxillin
and p130Cas, via their tyrosine phosphorylation, contribute
to efficient membrane spreading and ruffling with the differ-
ent downstream signalings.
 
Results
 
Mutation of Tyr31/118 of paxillin causes aberrant 
activation of RhoA
 
In migrating NMuMG cells, membrane ruffles prevail at the
leading edges, whereas stress fibers are formed at least several
 
 
 
m away from the cell periphery (Nakamura et al., 2000;
Fig. 1 B, a–c). We previously showed that expression of the
2X mutant of paxillin in migrating NMuMG cells causes
premature formation of stress fibers at the leading cell edges
with the concomitant loss of efficient membrane ruffles (Fig.
1 B, d–f), whereas expression of the 2Y mutant instead
causes apparent loss of cell polarity in migration (Nakamura
et al., 2000). We have also shown that the 2X mutant in-
duces aberrant formation of robust focal complexes at the
leading edges, which are apparently connected to stress fi-
bers, though the overall amounts of stress fibers were almost
unchanged compared to those in the parental cells (Fig. 1
B). Both 2X mutant and endogenous paxillin localizes to the
same aberrant focal complexes (Nakamura et al., 2000) . Im-
munoblotting using phosphorylation site-specific antibodies
revealed that the Tyr31/118 phosphorylation of endogenous
paxillin was significantly reduced in the 2X cells (Fig. 1 A).
Because the actin cytoskeletons was altered by expression
of the 2X mutant, we expressed mutants of Rho-family GTP-
ases in parental NMuMG cells and examined cellular phe-
notypes after inducing cells to migrate by scratching the
confluent culture. Similar to those induced by the 2X mu-
tant, expression of RhoA(G14V) induced premature forma-
tion of robust stress fibers and focal adhesions at the leading
edges, which accompanied substantial loss of lamellipodia
structures (Fig. 1 C, a–d). The constitutive active forms of
Rac1 and Cdc42 did not induce such phenotypes (Fig. 1 C,
e–l). To verify the involvement of integrin signaling, cells
were also examined at an early stage of adhesion onto col-
lagen. Unlike wild-type paxillin-expressing NMuMG cells
(Fig. 1 D, a–c), cells expressing the 2X mutant (Fig. 1 D,
d–f) or RhoA(G14V) (Fig. 1 D, g–j) were again found to ex-
hibit premature formation of stress fibers and formation of
robust aberrant focal complexes at the cell periphery, and
did not spread well. We then found that expression of
RhoA(T19N) in the 2X cells could restore the phenotypes to
almost normal: these cells exhibited efficient membrane ruf-
fles and do not form stress fibers directly at the leading cell
edges (Fig. 1 E, a–d). Expression of Rac1(G12V) also caused
similar restoration (Fig. 1 E, e–h). These restorations were
also confirmed at an early phase of cell adhesion (unpub-
lished data). On the other hand, the GTP binding-deficient
forms of Rac1 and Cdc42 did not cause such restorations:
2X cells expressing these mutants exhibited complicated
phenotypes of poorly formed lamellipodia and/or disorga-
nized stress fibers (Fig. 1 E, i–p). Expression levels of each of
the exogenous GTPases were confirmed to be similar by im-
munoblotting for the tag sequence (unpublished data). We
then measured RhoA activity and found that it became
higher in the 2X cells as compared to those in control cells
expressing wild-type enhanced GFP (EGFP)-paxillin during
adhesion to collagen (Fig. 1 F). Therefore, normal regula-
tion of Tyr31/118 phosphorylation of paxillin appears to be
necessary for efficient membrane spreading and ruffling, and
participates in the suppression of RhoA activity in cell adhe-
sion, and probably also in cell migration.
 
Identification of proteins binding 
to phosphorylated Tyr31/118 peptides
 
Several SH2-containing proteins have been shown to bind
to tyrosine phosphorylated paxillin, as mentioned earlier.
However, none of them seemed to interpret the mecha-
nism for the possible suppression of RhoA activity. Using
synthetic peptides, we reexamined the proteins that bind
to tyrosine phosphorylated paxillin (Fig. 2). Biotinylated
peptides, each corresponding to the four major tyrosine
phosphorylation sites of paxillin, were incubated with
NMuMG cell lysates, and proteins bound to the peptides
were precipitated using streptavidin-Sepharose beads. The
 
*Abbreviations used in this paper: EGFP, enhanced GFP; SH, src homology.  
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SH2 domains of Crk-II, Crk-L, and Csk have been shown
to bind to tyrosine phosphorylated paxillin. Immunoblot-
ting revealed that Crk-II, together with Crk-I and Crk-L, ef-
ficiently and specifically bind to the Tyr31 and Tyr118
peptides in their phosphorylated form. Csk was also recov-
ered efficiently by the Tyr118 phosphopeptide, but not by
other phosphopeptides or nonphosphorylated peptides. We
extended the identification by using antibodies against
other SH2-containing signaling molecules. We found that
p120RasGAP was efficiently precipitated by the Tyr31 and
Tyr118 phosphopeptides, but not by other peptides (Fig. 2).
Marginal levels of binding were also detected with several
proteins, such as Nck and the p85
 
 
 
 subunit of phosphati-
dylinositol-3-kinase, and binding was almost undetectable
with c-Src, Vav-2, Shc, and Shp-2 (Fig. 2; unpublished
data). In these assays, relative binding affinity of each pro-
tein was assessed by comparing amounts of proteins present
in total cell lysates to those precipitated.
 
Tyr31/118-phosphorylated paxillin binds to 
p120RasGAP via the two tandem SH2 domains
 
We then examined whether binding of paxillin and
p120RasGAP occurs intracellularly with endogenous pro-
teins. As shown in Fig. 3 A, immunoprecipitation of paxillin
from NMuMG cells using an anti-paxillin antibody copre-
cipitated p120RasGAP. Consistent with the above result of
the peptide binding assay, the amount of p120RasGAP co-
precipitating with paxillin became much higher when cells
Figure 1. The 2X mutant of paxillin induces phenotypes similar to those by RhoA(G14V) in NMuMG cells. (A) Phosphorylation of Tyr31 
and Tyr118 of endogenous paxillin ( ) and the EGFP-tagged 2X mutant ( ) in parental NMuMG cells (P) or the 2X-expressing cells (2X) were 
visualized using the phosphorylation site-specific antibodies (pY 31 and pY118). Paxillin was detected using an anti-paxillin antibody (pax). 
(B–E) Formation of stress fibers and membrane ruffles in migration (B, C, and E) or adhesion onto collagen type I (D). NMuMG cells expressing 
EGFP-tagged wild-type paxillin or the 2X mutant, or HA-tagged RhoA, Rac1, or Cdc42 mutants are shown, as indicated. F-actin was visualized 
by phalloidin, EGFP-tagged paxillin by autofluorescence of the tag, and Rho GTPases by an anti-HA antibody. Bars, 20  m. (F) NMuMG cells 
expressing EGFP-tagged wild-type paxillin (WT) or the 2X mutant (2X) were replated onto collagen coated dishes in the presence of 1% 
serum, and cell lysates prepared from each time point were incubated with GST-Rhotekin-RBD to measure the activities of RhoA. RhoA activity 
is indicated as percentages of the amount of RBD-bound RhoA normalized to the amount of RhoA in total cell lysates. Results are means 
 SEM from three independent experiments. 
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were pretreated with TGF
 
 
 
, in which paxillin phosphoryla-
tion at Tyr31/118, but not Tyr40/181, become highly aug-
mented (Nakamura et al., 2000). Several anti-p120RasGAP
antibodies have been shown to coprecipitate p120RasGAP-
binding proteins, such as p190RhoGAP (Ellis et al., 1990;
Moran et al., 1991; Settleman et al., 1992b). However, none
of these antibodies, including clone B4F8 (Settleman et
al., 1992a), could coprecipitate detectable amounts of paxil-
lin from NMuMG cell lysates, while coprecipitation of
p190RhoGAP could be detected (see Fig. 5).
p120RasGAP has two tandem SH2 domains, spaced by a
single SH3 domain (Trahey et al., 1988; Fig. 3 B). It has
been reported that the two SH2 domains of p120RasGAP
synergistically participate in binding to two sites of tyrosine
phosphorylation of p190RhoGAP, Tyr1087, and Tyr1105,
whereas each single SH2 domain of p120RasGAP exhibits
only weak binding to p190RhoGAP (Bryant et al., 1995;
Hu and Settleman, 1997). However, it should be noted that
others have suggested that the single major phosphorylation
at Tyr1105 is sufficient for binding (Roof et al., 1998). In
the case of paxillin binding to p120RasGAP, phosphory-
lated Tyr31 and Tyr118 of paxillin, and the two SH2 do-
mains of p120RasGAP appeared to be necessary. We found
that the glutathione 
 
S
 
-transferase (GST) fusion form of the
SH2-SH3-SH2 domain of p120RasGAP pulled down paxil-
lin from lysates of NMuMG cells, where again much higher
amounts were pulled down from TGF
 
 
 
-treated cells than
untreated cells (Fig. 3 C). On the other hand, the GST fu-
sion protein of either the NH
 
2
 
-terminal SH2 domain or the
COOH-terminal domain alone showed very weak or almost
undetectable binding (Fig. 3 C). Loss of function mutations
in the SH2 domains abolished its binding to paxillin, and
Figure 2. Protein binding to specific paxillin peptides. 500  g of 
TGF -treated NMuMG cell lysate was incubated with 250 pmol of 
the phosphorylated (P) and unphosphorylated ( ) forms of paxillin 
peptides immobilized on streptavidin-Sepharose beads, in a total 
volume of 500  l for 1 h at 4 C. Proteins precipitated were analyzed 
by immunoblotting using antibodies as indicated. The numbers 
indicate the peptides corresponding to the tyrosine phosphorylation 
sites of paxillin. 10  g of total cell lysate was included as controls 
(Total).
Figure 3. Tyr31/118-phosphorylated 
paxillin binds to p120RasGAP, via the 
two SH2 domains. (A) TGF -treated ( ) 
or untreated ( ) NMuMG cell lysates 
were immunoprecipitated with a mouse 
monoclonal anti-paxillin antibody 
coupled with anti–mouse IgG-Sepharose 
beads, and subjected to immunoblotting, 
as indicated. (B and C) TGF -treated ( ) 
or untreated ( ) NMuMG cell lysates 
were incubated with GST fusion 
proteins, each corresponding to various 
parts of the SH2-SH3-SH2 domain of 
p120RasGAP (B), and proteins bound 
to the beads were analyzed by immuno-
blotting, as indicated (C). Asterisks 
indicate mutations in the SH2 domains. 
Coomassie blue staining of the GST 
proteins used are also shown (CBB). 
(D) The GST-SH2-SH3-SH2 protein was 
preincubated with 100  M each of the 
phosphorylated or unphosphorylated 
paxillin peptides (or combinations of 
peptides), as indicated, before being 
incubated with TGF -treated NMuMG 
cell lysate, and bound proteins were 
subjected to anti-paxillin blotting. (E) 
TGF -treated NMuMG cell lysates were 
incubated with a mouse monoclonal 
anti-paxillin antibody (IP) or the GST-
SH2-SH3-SH2 protein, and bound 
proteins were analyzed using phosphor-
ylation site-specific antibodies for paxil-
lin (pY31, pY40, pY118 and pY181) or 
an anti-paxillin antibody, as indicated. 20 pmol each of the paxillin peptides used in Fig. 2 was spotted onto filters and used as controls (right). 
Total cell lysate (Total) or cell lysate incubated with GST were included as controls, and the molecular sizes in kD are shown, where necessary. 
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the SH3 domain alone did not precipitate paxillin at detect-
able levels (Fig. 3 C). However, it should be noted that only
a marginal level of p190RhoGAP was detected to be bound
to the SH2-SH3-SH2 protein (Fig. 3 C), as reported previ-
ously (Ellis et al., 1991). In several previous reports, purified
recombinant proteins at high concentrations or proteins in-
tracellularly overexpressed by cDNA transfection were used
to show binding of p190RhoGAP to the GST-SH2-SH3-
SH2 domain (Bryant et al., 1995; Hu and Settleman, 1997).
p130Cas, Pyk2, and Fak, all highly tyrosine phosphorylated
in NMuMG cells, were not detected to bind to the SH2-
SH3-SH2 domain (Fig. 3 C).
Phosphorylated Tyr31 and Tyr118 peptides, either alone
or in combination, but not the nonphosphorylated peptides,
blocked the binding of the GST-SH2-SH3-SH2 to tyrosine
phosphorylated paxillin (Fig. 3 D). Moreover, blotting of
paxillin with phosphorylation site-specific antibodies also
supported the notion that Tyr31- and Tyr118-phosphory-
lated paxillin, but not the Tyr40- or Tyr181-phosphorylated
forms, binds to the p120RasGAP SH2-SH3-SH2 domain
(Fig. 3 E).
 
p120RasGAP colocalizes with Tyr31/118-phosphorylated 
paxillin at the cell periphery but not at focal adhesions
 
We then examined the subcellular colocalization of paxillin
and p120RasGAP. Tyr31/118-phosphorylated paxillin lo-
calizes both to the leading cell edges and focal adhesions
in migrating NMuMG cells (Nakamura et al., 2000).
p120RasGAP molecules, tagged with HA, were also found
to localize to the leading cell edges in migrating NMuMG
cells, where it was well colocalized with Tyr31/118-phos-
phorylated paxillin (Fig. 4 A; unpublished data). On the
other hand, p120RasGAP did not accumulate at the focal
adhesions and was diffusely distributed throughout the cyto-
plasm (Fig. 4 A). Absence of p120RasGAP accumulation at
focal adhesions was also confirmed using p120RasGAP
tagged with EGFP, by detecting autofluorescence from the
tag (unpublished data). On the other hand, in the migrating
2X cells, p120RasGAP could no longer be detected clearly at
the cell periphery or at the aberrant focal complexes formed
at the cell periphery (Fig. 4 B). Similar levels of expression of
HA-p120RasGAP in these cells were confirmed (Fig. 4 C).
Because p120RasGAP binds to p190RhoGAP, the subcel-
lular localization of p190RhoGAP was also investigated.
Like p120RasGAP, this protein was also found at the cell
periphery but not accumulated at focal adhesions in mi-
grating NMuMG cells (Fig. 4 A). Again, expression of
the 2X mutant abolished the peripheral localization of
p190RhoGAP (Fig. 4 B).
 
Blockage of p190RhoGAP binding to p120RasGAP 
by Tyr31/118-phosphorylated paxillin
 
We then examined whether binding of Tyr31/118-phos-
phorylated paxillin to p120RasGAP affects intracellular
binding of p190RhoGAP to p120RasGAP. For this, we first
confirmed that the Tyr31- and Tyr118-phosphorylated pep-
tides have the ability to block the binding of p190RhoGAP
to the GST-SH2-SH3-SH2 protein of p120RasGAP in
vitro (Fig. 5 A). To examine the possible competition
between paxillin and p190RhoGAP toward binding to
p120RasGAP, transient protein overexpression in COS7
cells was used. We found that overexpression of EGFP-
p190RhoGAP significantly reduced the amounts of
p120RasGAP coprecipitating with an anti-paxillin anti-
body, with a concomitant increase in the amounts of
p190RhoGAP and its EGFP fusion protein coprecipitating
with an anti-p120RasGAP antibody (Fig. 5 B). Overexpres-
sion of wild type EGFP-paxillin was similarly found to de-
crease the amount of RhoGAP coprecipitating with an anti-
RasGAP antibody (Fig. 5 C). The transient overexpression
method was not applicable for NMuMG cells, as NMuMG
cells overexpressing p190RhoGAP at high levels could not
adequately adhere to the extracellular matrices and tyrosine
phosphorylation of paxillin in these cells became much re-
duced (Fig. 6; unpublished data). Hence, we addressed this
issue with NMuMG cells stably expressing EGFP-tagged
wild type paxillin or the 2X mutant. In this regard, it should
be noted that Tyr31/118-phosphorylation of endogenous
Figure 4. Colocalization of paxillin, p120RasGAP, and p190RhoGAP 
at the cell periphery, but not at focal adhesions. HA-p120RasGAP 
was stably expressed at a low level in NMuMG cells expressing 
EGFP-tagged wild-type paxillin (A) or the 2X mutant (B), and cells 
were analyzed during migration. EGFP-paxillin was visualized by 
autofluorescence from the tag. HA-p120RasGAP and endogenous 
p190RhoGAP were visualized using an anti-HA antibody and an 
anti-p190RhoGAP antibody, respectively, coupled with Cy5-
conjugated anti–mouse IgG. Each right panel is the merged image 
of the left and middle panels. Bars, 20  m. Levels of HA-tagged and 
endogenous p120RasGAP expression in these cells (WT and 2X) are 
shown by immunoblotting, as indicated (C). Parental NMuMG cells 
were also included (P). 
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paxillin is greatly reduced in the 2X cells (Fig. 1 A). Com-
pared with the parental cells, we found that the amount of
p190RhoGAP coprecipitating with the anti-p120RasGAP
antibody was notably reduced in cells expressing wild-type
EGFP-paxillin, and was significantly increased in the 2X ex-
pressing cells (Fig. 5 D). The expression levels of wild-type
EGFP-paxillin and the 2X mutant were very similar in these
cells (Fig. 5 D). A similar effect was also seen when the 2X
mutant was overexpressed in COS7 cells (Fig. 5 C). These
results collectively support a notion that Tyr31/118-phos-
phorylated paxillin and p190RhoGAP act competitively
in their binding to p120RasGAP, and changes in Tyr31/
118 phosphorylation affects the intracellular amounts of
p190RhoGAP in complex with p120RasGAP.
Figure 6. p190RhoGAP overexpression can restore the 2X-induced 
phenotypes. Confluent cultures of NMuMG cells expressing the 2X 
mutant were scratched. Cells at the wound edges were microinjected 
with the pEGFP-p190RhoGAP plasmid, and incubated for 12 h 
before fixation. Cloned cells stably expressing the paxillin 2X mutant 
not tagged with EGFP were used, in which expression of the 2X 
mutant was confirmed using an anti-paxillin and phosphorylation 
site-specific antibodies as in Fig. 1 A. Mutant and endogenous 
paxillin were visualized using an anti-paxillin antibody coupled 
with Cy5-conjugated anti–mouse IgG. F-actin and EGFP-p190RhoGAP 
were visualized using phalloidin and by the autofluorescence from 
the tag, respectively. The right panel is the merged image of the left 
three panels. Cells were classified into four groups, based on the 
levels of EGFP-RhoGAP expression, which was measured optically 
from the autofluorescence from the tag. Levels of EGFP-RhoGAP 
expression were also assessed by staining cells with an anti-RhoGAP 
antibody and compared with those of endogenous p190RhoGAP in 
untransfected cells. Levels of EGFP-RhoGAP in each cell of the low 
level expressors (L) correspond to about the same as that of endoge-
nous p190RhoGAP, the medium (M) correspond to approximately 
two- to threefold higher, the high (H) correspond to approximately 
three- to fivefold fold higher, and super high (S) correspond to more 
than fivefold higher. Representative examples are shown from more 
than 100 cells examined. Bar, 20  m.
 
Figure 5.
 
Competition of Tyr31/118-phosphorylated paxillin with 
p190RhoGAP for binding to p120RasGAP.
 
 (A) 3Y1/v-Src cell lysates 
were incubated with the p120RasGAP GST-SH2-SH3-SH2 protein, 
preincubated with a paxillin peptide (or combinations of peptides) 
as in Fig. 3 E. The control included the GST fusion protein without 
incubation with peptides (
 
 
 
). Proteins precipitated were analyzed 
by anti-p190RhoGAP immunoblotting. (B and C) COS7 cells were 
transiently transfected with 0, 1, or 3 
 
 
 
g of pEGFP-RhoGAP, as 
indicated (B), or transfected with 3 
 
 
 
g of pBabe/EGFP-paxillin (WT) 
or 3 
 
 
 
g of pBabe/EGFP-paxillin 2X (2X), as indicate (C). Mock-
transfected cells were also included (C, P). 24 h later, cells were 
detached from culture dishes by incubation with PBS containing 5 
mM EDTA, washed, and replated onto collagen type I–coated dishes 
in the presence of 0.5% BSA for 1 h. Cells were then lysed, and 
protein coprecipitation was analyzed using an anti-paxillin antibody 
coupled with anti–mouse IgG-Sepharose beads (B), or an anti-RasGAP 
antibody (clone B4F8) coupled with protein A-Sepharose beads (C). 
Protein immunoblotting was performed as indicated, with immuno-
precipitated proteins (IP) and total cell lysates (Total). (D) Amounts 
of p190RhoGAP coprecipitating with p120RasGAP using antibody 
B4F8 were analyzed, as above, with cell lysates from parental 
NMuMG cells (P), or NMuMG cells expressing EGFP-paxillin (WT) 
or cells expressing the 2X mutant (2X), all pretreated with TGF
 
 
 
. 
 
(C and D) To show the difference in the amounts of p190RhoGAP 
coprecipitating with p120RasGAP, a longer exposure of the immuno-
blots shown on the top of each panel, is also shown at the bottom. 
Exposure time was 15 s for the top, and 2 min for the bottom. 
(B–D) Total cell lysates were included as controls (Total). Molecular 
sizes are shown on the left. 
 
 
 
, endogenous paxillin; 
 
 
 
, EGFP-
tagged paxillin. 
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Suppression of the 2X phenotypes by p190RhoGAP
 
We next examined whether p190RhoGAP can suppress the
phenotypes induced by expression of the 2X mutant.
NMuMG cells stably expressing the 2X mutant were sub-
jected to cloning, and cells with a clonal origin were micro-
injected with the EGFP-p190RhoGAP plasmid, and their
cytoskeletal organization during migration were analyzed. As
shown in Fig. 6, overexpression of EGFP-p190RhoGAP was
able to suppress the 2X-induced phenotypes and restored ef-
ficient membrane ruffles and normal formation of stress fi-
bers (Fig. 6 M). However, such restoration seemed to re-
quire the expression of appropriate levels of p190RhoGAP.
In the 2X cells expressing EGFP-p190RhoGAP at relatively
high levels, stress fiber formation was substantially blocked,
and cell adhesion was hampered (Fig. 6, H and S). On the
other hand, when EGFP-p190RhoGAP expression was too
low, the 2X phenotypes were not significantly suppressed
(Fig. 6 L). These observations suggest that the ratio between
p190RhoGAP and the 2X mutant is important in determin-
ing the formation of membrane ruffles and appropriate stress
fibers. Unlike p190RhoGAP, overexpression of p120RasGAP
could not restore the 2X phenotype (unpublished data).
 
p120RasGAP is necessary for the efficient activation of 
RhoA in cell adhesion
 
The important question that then remained was whether
p190RhoGAP not associated with p120RasGAP can effi-
ciently suppress RhoA activity in vivo. To assess this issue,
we disrupted p120RasGAP expression by the siRNA tech-
nique (Elbashir et al., 2001). We succeeded in the effec-
tive and specific inhibition of p120RasGAP protein expres-
sion in HeLa cells, whereas the intracellular amount of
p190RhoGAP expression was unaffected (Fig. 7 A). Expres-
sion of p130Cas was also substantially blocked by treating
cells with its specific siRNA, and this was used as a control,
together with oligonucleotides with an irrelevant sequence
(Fig. 7 A). We found that the activation of RhoA is signifi-
cantly hampered during cell adhesion, when p120RasGAP
expression is inhibited (Fig. 7 B). We also confirmed that
overexpression of EGFP-p190RhoGAP in HeLa cells blocked
the activation of RhoA in adhesion (Fig. 7 B). In cells in
which p120RasGAP expression was inhibited, stress fibers
were not formed and cortical actin structures of membrane
ruffles were significantly augmented, similar to that seen in
the EGFP-p190RhoGAP overexpressing cells (Arthur and
Burridge, 2001; Fig. 7 C). Therefore, the presence of
p120RasGAP at a normal level seems to be necessary for the
efficient activation of RhoA in adhesion of HeLa cells.
 
Discussion
 
We show here that paxillin, through its Tyr31/118 phos-
phorylation, participates in suppression of RhoA activity in
cell adhesion and migration in NMuMG cells. We have
shown previously that tyrosine phosphorylation of paxillin
and p130Cas is the prominent event induced upon integrin
engagement in NMuMG cells (Nakamura et al., 2001). We
have also demonstrated that overexpression of paxillin and
p130Cas exert opposing effects on cell migratory activities,
through their tyrosine phosphorylation (Yano et al., 2000).
Tyrosine phosphorylation of p130Cas has been shown to act
to enhance membrane ruffle formation, possibly by binding
to Crk proteins (Dolfi et al., 1998; Hashimoto et al., 1998;
Girardin and Yaniv, 2001). p130Cas does not bind to
p120RasGAP. Therefore, both p130Cas and paxillin appear
to contribute to the efficient formation of membrane ruffles
in cell adhesion and migration, but by distinct signaling
pathways; the former is likely to act by enhancing Rac1 ac-
tivity (Dolfi et al., 1998; Hashimoto et al., 1998; Girardin
and Yaniv, 2001), whereas the latter is likely to act by sup-
pressing RhoA activity (as shown in this paper). The fact
that a dysfunction in Tyr31/118 phosphorylation causes
substantial loss of membrane spreading and ruffling suggests
that appropriate paxillin phosphorylation is essential for
these events in NMuMG cells, even in the presence of intact
p130Cas molecules.
Figure 7. Blockage of p120RasGAP expression hampers efficient 
activation of RhoA in cell adhesion. HeLa cells were treated with 
60 nM oligonucleotides in culture medium, designed for the siRNA-
mediated specific disruption of p120RasGAP expression or
of p130Cas expression, or transfected with pcDNA/EGFP-
p190RhoGAP for its overexpression, as indicated. Oligonucleotides 
with an irrelevant sequence (irr), were included as a negative 
control. After 24 h, cells were starved of serum for a further 24 h, 
detached from culture dishes by incubation with PBS containing 5 
mM EDTA, and washed and replated onto collagen type I coated 
dishes in the presence of 1% serum. (A) Protein expression in each 
cell preparation is shown, by immunoblotting. (B) RhoA activity was 
measured at each time point, as in Fig. 1 F. Results are means  SEM 
from three independent experiments. (C) F-actin was visualized in 
red, in cells pretreated as indicated and fixed 60 min after adhesion. 
Expression of EGFP-p190RhoGAP, detected by autofluorescence 
from the tag, was shown in green. Bar, 20  m. 
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We showed that paxillin, through its Tyr31/181 phos-
phorylation, binds to p120RasGAP. It has been shown that
the major cellular complex formed by p120RasGAP is that
with p190RhoGAP (Moran et al., 1991; Settleman et al.,
1992a, 1992b), although about half a dozen of tyrosine
phosphorylated proteins have been identified as binding to
the p120RasGAP SH2 domains. Among the several differ-
ent GAP proteins for RhoA, p190RhoGAP has been shown
to be the major GAP regulating integrin-mediated RhoA
activity, and suppresses RhoA-mediated stress fiber forma-
tion (Ridley et al., 1993; Arthur and Burridge, 2001).
p190RhoGAP has also been shown to be necessary for
efficient membrane ruffle formation and cell migration:
suppression of RhoA activity by p190RhoGAP in turn pro-
motes membrane protrusion, ruffling, and spreading (Ar-
thur and Burridge, 2001). We showed that paxillin binds to
p120RasGAP in a similar manner to that proposed for
p190RhoGAP binding to p120RasGAP, where the two
SH2 domains and two sites of tyrosine phosphorylation ap-
pear to be required. However, it should be noted that
p190RhoGAP can also bind to p120RasGAP independently
of the tyrosine phosphorylations (Hu and Settleman, 1997;
Roof et al., 1998). However, this tyrosine phosphorylation-
independent association appears to comprise only 10–20%
of the complexes formed in vivo (Roof et al., 1998). There-
fore, the binding of paxillin to p120RasGAP and the bind-
ing of p190RhoGAP to p120RasGAP may be substantially
mutually exclusive, unless these interactions take place at
distinct places within a cell. All three proteins were found
colocalized at the leading cell edges in migrating NMuMG
cells. We also provide several lines of evidence that Tyr31/
118 phosphorylation of paxillin is competitive with
p190RhoGAP in binding to p120RasGAP, and the phos-
phorylation status of paxillin at Tyr31/118 affects the
intracellular amount of p190RhoGAP complexed with
p120RasGAP.
The regulatory mechanism of the GAP activity of
p190RhoGAP has not been established. It has been hypoth-
esized from experiments using Rat-2 fibroblasts expressing
the NH
 
2
 
-terminal half of p120RasGAP bearing the SH2-
SH3-SH2 domain (GAP-N) that p190RhoGAP complexed
with p120RasGAP may have higher and more efficient
GAPing activity for Rho in vivo than that of the monomeric
form of p190RhoGAP (McGlade et al., 1993). In contrast,
there is also an opposite belief that the p120RasGAP/
p190RhoGAP complex may be a default status for both pro-
teins with regard to their GAP activities in vivo: these pro-
teins in complex are soluble, having either the SH2 domains
or the tyrosine phosphorylation sites occupied by complex
formation, and may therefore be unable to efficiently access
each of their membrane bound targets, Ras and Rho (Bry-
ant et al., 1995). A biochemical assay has revealed that
p120RasGAP molecules in complex with p190RhoGAP ex-
hibits an approximately fourfold decrease in GAP activity, as
compared to that of the monomeric form (Moran et al.,
1991). We observed that inhibition of p120RasGAP protein
expression in HeLa cells hampers the efficient activation of
RhoA upon cell adhesion. This result, as well as the above
described results of the expression of the 2X mutant in
NMuMG cells, are consistent with the latter hypothesis.
Unfortunately, the siRNA method has so far been applicable
only for several cell lines in our laboratory, and we were not
able to perform the same experiment using NMuMG cells.
Based on our results and results from the literature as al-
ready mentioned, we propose a model as to how Tyr31/118-
phosphorylated paxillin participates in the suppression of
RhoA activity in cell adhesion and migration. Paxillin
is phosphorylated both at Tyr31 and Tyr118 upon inte-
grin activation at the leading cell edges and binds to
p120RasGAP. This binding is in competition with
p190RhoGAP binding to p120RasGAP, and thus increases
the amounts of p190RhoGAP not complexed with
p120RasGAP. p190RhoGAP, freed from p120RasGAP,
may then efficiently access RhoA molecules at or near the
cell periphery and suppress their activity, as a monomeric
protein or even by binding to other SH2-containing pro-
teins via the freed phosphorylation sites.
Unlike in HeLa cells, we found that RhoA activity in the
p120RasGAP-deficient cells derived from p120RasGAP
gene knockout mice (Kulkarni et al., 2000) is not signifi-
cantly higher than that in these cells back-transfected with
full-length p120RasGAP, during adhesion to fibronectin
(unpublished data). The p120RasGAP-deficient cells appear
to have originated from fibroblasts, as they were established
by culturing embryonic tissue after early passage cells under-
went crisis, and they respond to PDGF (Kulkarni et al.,
2000). It is documented that RhoA activity is relatively high
in cultured fibroblasts such as NIH3T3, and activation
of Rac by Tiam1 in NIH3T3 cells induces an epithelial-
like morphology with functional cadherin-based adhesions
(Sander et al., 1999). In cells such as NIH3T3 cells and
p120RasGAP-deficient cells, robust stress fibers are formed
directly at the cell periphery, as seen in the 2X-expressing
NMuMG cells. The p120RasGAP-deficient cells back trans-
fected with p120RasGAP also form robust stress fibers di-
rectly at the cell periphery (unpublished data). We have
shown that 2X NMuMG cells fail to immediately disassem-
ble their stress fibers and focal adhesions upon cell–cell colli-
sion, which occurs quickly upon cell collision in the parental
cells to form the cadherin-mediated cell–cell adhesions (Na-
kamura et al., 2000). We have also found that expression of
the 2X mutant in fibroblasts such as 3Y1 cells and NIH3T3
cells, does not further enhance stress fiber formation (Naka-
mura et al., 2000). Thus, the suppression of RhoA activity,
via the possible interaction of p120RasGAP with Tyr31/
118-phosphorylated paxillin, appears to be cell-type specific,
and does not always function efficiently in cultured fibro-
blasts, which may have the intrinsic ability to activate RhoA
at a high level to form robust stress fibers at the cell periph-
ery (see below).
In addition to the leading cell edges, Tyr31/118-phosphor-
ylated paxillin also accumulates at focal adhesions under-
neath the cell body in migrating NMuMG cells. Neverthe-
less, p120RasGAP does not accumulate at focal adhesions in
NMuMG cells. Several different proteins bind to the phos-
phorylated Tyr31/118 of paxillin. Therefore, Tyr31/118-
phosphorylated paxillin may bind to proteins other than
p120RasGAP at focal adhesions and be engaged in different
signaling pathways, which may or may not contribute to the
formation of stress fibers. The ability of Tyr31/118-phos- 
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phorylated paxillin to engage in different downstream sig-
naling pathways may result from the different roles played
by the paxillin Tyr31/118 phosphorylation in different cel-
lular contexts, as seen in previous reports (Petit et al., 2000;
Yano et al., 2000) and in different cell types such as
NMuMG epithelial cells and several fibroblasts as discussed
above. Like paxillin, many other integrin-assembly proteins
and their phosphorylation events occur both at membrane
ruffles and focal adhesions. The mechanisms of how such
proteins possibly select different downstream signaling path-
ways still remain largely elusive.
It has been reported from analysis of p120RasGAP-defi-
cient cells that complex formation of p120RasGAP and
p190RhoGAP appears to be important for cell polarization,
by regulating stress fiber and focal adhesion reorientation
(Kulkarni et al., 2000). It has also been reported that overex-
pression of the GAP-N protein of p120RasGAP causes ir-
regular and branched formation of stress fibers (McGlade et
al., 1993). Significant alterations in stress fiber organization
was also observed in NMuMG cells when GAP-N was over-
expressed (unpublished data). However, we have yet to ana-
lyze whether the p120RasGAP and p190RhoGAP complex
is involved in cell polarity or branching activity in NMuMG
cells. Moreover, we have not yet fully analyzed the biological
significance of the p120RasGAP molecules associated with
paxillin. It is possible that p120RasGAP bind to paxillin
only to release p190RhoGAP. Alternatively, binding of
Tyr31/118-phosphorylated paxillin to p120RasGAP may
act to recruit p120RasGAP molecules to sites of integrin ac-
tivation, similar to the case of p120RasGAP binding to acti-
vated growth factor receptors (Kazlauskas et al., 1990; Mo-
ran et al., 1991; Molloy et al., 1992).
In conclusion, we have shown that paxillin, through its
phosphorylation at Tyr31/118, contributes to efficient
membrane spreading and ruffling, by suppressing RhoA
activity. The flexible structure of membrane ruffles at the
leading cell edges might be advantageous for the efficient
perception of cell-cell collision and the subsequent forma-
tion of cell–cell adhesion. For the integrity of cytoarchitec-
ture and its efficient remodeling, spatially and temporally
coordinated regulation of the different Rho-family GTP-
ases, such as RhoA, Rac1, and Cdc42, are necessary
within a single cell. The complementary, but potentially
opposing effects between paxillin tyrosine phosphorylation
and p130Cas tyrosine phosphorylation may more generally
be involved in the hierarchical and/or mutually exclusive
regulation of activities of these GTPases in cell adhesion
and migration (for review see Hall, 1998; also see Sander et
al., 1999; Cox et al., 2001): such are issues that deserve
further experimental scrutiny.
 
Materials and methods
 
Cells
 
NMuMG cells (Miettinen et al., 1994) stably expressing EGFP-tagged pax-
illin cDNAs, and their treatment with TGF-
 
 
 
1 (R&D Systems) have been
described previously (Nakamura et al., 2000). COS7, HeLa, and 3Y1 cells
were cultured as described previously (Yano et al., 2000; Mazaki et al.,
2001). Cell migration was induced by scratching the confluent cultures as
described (Nakamura et al., 2000). Cell adhesion to collagen was per-
formed as described (Mazaki et al., 2001) by plating cells onto 10 
 
 
 
g/ml
collagen type I–coated plates in the presence of 1% serum.
 
Antibodies
 
Phosphorylation site-specific antibodies against each of the four major ty-
rosine phosphorylation sites of paxillin were generated by Biosource Inter-
national (Nakamura et al., 2000). Src (Ab327) and Csk antibodies were as
described previously (Sabe et al., 1994). Other antibodies against the fol-
lowing proteins were purchased from commercial sources: paxillin, Crk-I/
II, Fak, Pyk2, p130Cas, p120RasGAP, and p190RhoGAP were from TDL;
Rac1, Cdc42, p85 of PI3K, Shc, and Shp-2 were from UBI; RhoA, Nck,
Crk-L, and p120RasGAP (clone B4F8) were from Santa Cruz Biotechnol-
ogy, Inc.; and HA and GST were from Berkeley Antibody. Affinity-purified
donkey antibodies to rabbit or mouse IgG conjugated either with horserad-
ish peroxidase or Cy5 were from Jackson ImmunoResearch Laboratories.
 
cDNAs and their expression
 
Human p120RasGAP cDNA was amplified by PCR from the first strand
cDNAs prepared from mRNAs of human fetal brain (CLONTECH Laboratories,
Inc.), and ligated into pBabePuro/EGFP (Nakamura et al., 2000) to be fused
in-frame to the COOH terminus of EGFP, or into pBabeHygro/HA
 
3
 
 to be
tagged with three repeats of the HA sequence at the NH
 
2
 
 terminus. GST fu-
sion forms of the SH2-SH3-SH2 domain or its derivatives were constructed
in pGEX4T-1 (Amersham Biosciences), according to a previous report (Hu
and Settleman, 1997). Mutations were introduced into the SH2 domains, in
which Arg207 and Arg377 were changed to leucines (Songyang et al.,
1995). Human p190RhoGAP cDNA (KIAA 0174) was obtained from Kazusa
DNA Research Institute, and used after its missense mutations were cor-
rected. The RhoGAP cDNA was ligated into pEGFP, to be expressed as
NH
 
2
 
-terminal tagged proteins. Nucleotide sequences were confirmed for
all the plasmids after construction. cDNAs in pBabeHygro each encod-
ing HA
 
3
 
-tagged RhoA(G14V), RhoA (T19V), Rac1(G12V), Rac1(T17N),
Cdc42(G12V), and Cdc42(T17N) were from K. Kaibuchi (Nagoya Univer-
sity, Nagoya, Japan). pGEX-2T/p120RasGAP SH2(N) and pGEX-Rhotekin
RBD were gifts from B. Mayer (University of Connecticut, Farmington, CT)
and M.A. Schwartz (University of Virginia, Charlottesville, VA), respectively.
cDNAs in the pBabe vectors were expressed by the use of the BOSC23-
derived retrovirus-mediated infection technique (Pear et al., 1993), and
cells were selected for three days in the presence of 1 
 
 
 
g/ml Puromycin
(Sigma-Aldrich) or 0.6 mg/ml of Hygromycin B (Life Technologies) before
being subjected to analysis, as described previously (Nakamura et al.,
2000). For transient expression, COS7 and HeLa cells were transfected
with plasmid DNAs using Polyfect (QIAGEN). Expression and purification
of GST fusion proteins in an 
 
Escherichia coli 
 
system were as described
(Sabe et al., 1994).
 
Protein binding and immunoblotting
 
In vitro protein binding assays using GST fusion proteins were performed
as described (Settleman et al., 1992a; Sabe et al., 1994) with slight modifi-
cations. Briefly, cell lysates were prepared in 1% Triton X-100 buffer (20
mM Hepes, pH 7.4, 150 mM NaCl, 1.5 mM MgCl
 
2
 
, 5 mM EGTA, 1% Tri-
ton X-100, 10% glycerol, 1 mM Na
 
3
 
VO
 
4
 
, 10 
 
 
 
M Na
 
3
 
MgO
 
4
 
, 1 mM phenyl-
methylsulfonyl fluoride, 2 
 
 
 
g/ml leupeptin, 3 
 
 
 
g/ml pepstatin A, 10 
 
 
 
g/ml
aprotinin; Settleman et al., 1992a). Washing of precipitates was done with
0.1% Triton X-100 buffer, which contains Triton X-100 at 0.1% instead of
at 1% and 1 mM EDTA instead of Mg
 
2
 
 
 
 in the above buffer. In each experi-
ment, 250 
 
 
 
g of cell lysate and 5 
 
 
 
g of GST-fusion protein bound to glu-
tathione-Sepharose beads (Amersham Biosciences) were used. Immuno-
precipitation was also done using 500 
 
 
 
g of cell lysate prepared in 1%
Triton X-100 buffer and the appropriate antibodies bound to Protein
A-Sepharose beads (Amersham Biosciences), or to anti–mouse IgG-Seph-
arose beads (Sigma-Aldrich), as described (Tachibana et al., 1995). Deter-
mination of protein concentrations, SDS-PAGE and immunoblotting were
done as described (Sabe et al., 1994). In each figure, 10 
 
 
 
g of total cell ly-
sates was included as a control, if necessary. Antibodies retained on the
membranes were visualized using an enzyme-linked chemiluminescence
method (Amersham Biosciences).
For peptide binding analysis, the NH
 
2
 
-terminal succinimidyl-6-(biotin-
amide) hexanoate linked peptides, either nonphosphorylated or phosphory-
lated on tyrosines, were synthesized in milligram quantities by Peptide
Institute (Osaka, Japan). Sequences of each peptide, as well as the
phosphorylation sites, were EETPpYSYPTGNH for Tyr31, GNHTpYQEIA-
VPP for Tyr40, EEHVpYSFPNKQK for Tyr118, and LSPLpYGVPETNS for
Tyr181. Peptide competition analyses were done as described (Hu and
Settleman, 1997).
 
siRNA-mediated disruption of p120RasGAP expression
 
Inhibition of p120RasGAP expression in HeLa cells was done by use of the
siRNA technique (Elbashir et al., 2001). Oligonucleotides for human 
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p120RasGAP siRNA were designed (5
 
 
 
-AACUGCCCACUUCGUUGCUU-
GUU-3
 
 
 
 and 5
 
 
 
-CAAGCAACGAAGUGGGCAGUUUU-3
 
 
 
), and trans-
fected into cells using Polyfect (QIAGEN), according to the manufacturer’s
instructions. As controls, oligonucleotides for human p130Cas siRNA (5
 
 
 
-
ACCACCACGCAGUCUACGACGUU-3
 
 
 
 and 5
 
 
 
-CGUCGUAGACUGCG-
UGGUGGUUU-3
 
 
 
), and oligonucleotides with a similar length but irrele-
vant sequence (irr) (5
 
 
 
-AUCCGAAGAGAAAGCAGUCCCUU-3
 
 
 
 and 5
 
 
 
-
GGGACUGCUUUCUCUUCGGAUUU-3 ) were used.
RhoA activity
RhoA activities were measured using Rhotekin GST-RBD in cell adhesion
to extracellular matrices in the presence of 1% serum, as described (Ren et
al., 1999). Precipitated Rho proteins were quantified by immunoblotting
using the monoclonal antibody against RhoA, coupled with their densito-
metric analysis using NIH Image 1.61 software (National Institutes of
Health [Research Service Branch]).
Laser confocal microscopy
Cells were fixed in 4% paraformaldehyde at 37 C, 4 h after the induction
of migration or 1 h after their adhesion to collagen, unless otherwise indi-
cated, and analyzed using laser confocal microscopy with the attached
computer software (LSM 510 version 2.5; Carl Zeiss), as previously de-
scribed (Nakamura et al., 2000). Optical measurement of protein expres-
sion in a single cell was performed as described previously (Uchida et al.,
2001). Antibodies were used at 1  g/ml for the anti-HA antibody, and 2.5
 g/ml for the anti-p190RhoGAP antibody. Fluorescence dye–conjugated
secondary antibodies were used at 1:1,000 dilution. F-actin was visualized
by incubation for 1 h with Texas red–X phalloidin (Molecular Probes) at
1:600 dilution. EGFP-tagged proteins were visualized by autofluorescence
from the tag. Each figure of microscopic analysis shows representative re-
sults that were observed in a majority of the cDNA-transfected cells in at
least three independent experiments ( 60–70% of the population in 100–
200 cells examined) unless otherwise indicated.
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